Alan David Borthwick | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Alan David Borthwick is active.

Explore More

Publication

Featured researches published by Alan David Borthwick.

Bioorganic & Medicinal Chemistry | 2017

Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist

Earl Clarke; Christopher I. Jarvis; Maria B. Goncalves; S. Barret Kalindjian; David Reginald Adams; Jane Theresa Brown; Jason J. Shiers; David Michel Adrien Taddei; Elodie Ravier; Stephanie Barlow; Iain Miller; Vanessa Smith; Alan David Borthwick; Jonathan Corcoran

Graphical abstract

Journal of Medicinal Chemistry | 2006

Pyridyl-2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists: Synthesis, Pharmacokinetics, and In Vivo Potency

Alan David Borthwick; John Liddle; Dave E. Davies; Anne M. Exall; Christopher Hamlett; Deirdre Mary Bernadette Hickey; Andrew Mcmurtrie Mason; Ian Edward David Smith; Fabrizio Nerozzi; Simon Peace; Derek Pollard; Steve L. Sollis; Michael J. Allen; Patrick M. Woollard; Mark Pullen; Timothy D. Westfall; Dinesh J. Stanislaus

Journal of Medicinal Chemistry | 2007

Factor Xa Inhibitors: S1 Binding Interactions of a Series of N-{(3S)-1-[(1S)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}Sulfonamides.

Chuen Chan; Alan David Borthwick; David W. Brown; Cynthia L. Burns-Kurtis; Matthew Campbell; Laiq Chaudry; Chun-wa Chung; J. Nicole Hamblin; Lisa Johnstone; Henry A. Kelly; Savvas Kleanthous; Angela Patikis; Champa Patel; Anthony J. Pateman; Stefan Senger; Gita P. Shah; John R. Toomey; Nigel S. Watson; Helen E. Weston; Caroline Whitworth; and Robert J. Young; Ping Zhou

American Journal of Physiology-regulatory Integrative and Comparative Physiology | 2007

Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat

Gerald P. McCafferty; Mark Pullen; Charlene Wu; Richard M. Edwards; Michael J. Allen; Patrick M. Woollard; Alan David Borthwick; John Liddle; Deirdre Mary Bernadette Hickey; David P. Brooks; Timothy D. Westfall

Archive | 2004

Pyrrolidine -2-ones as factor xa inhibitors

Alan David Borthwick; Henry A. Kelly; Nigel S. Watson; Robert J. Young

Journal of Medicinal Chemistry | 2010

Oral Oxytocin Antagonists

Alan David Borthwick

Archive | 2002

Substituted diketopiperazines as oxytocin antagonists

Alan David Borthwick; Richard Jonathan Hatley; Deirdre Mary Bernadette Hickey; John Liddle; David G. Livermore; Andrew Mcmurtrie Mason; Neil Derek Miller; Fabrizio Nerozzi; Steven Leslie Sollis; Anna Katrin Szardenings; Paul G. Wyatt

Archive | 2002

2-(3-Sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors

Alan David Borthwick; Matthew GlaxoSmithKline Campbell; Chuen Glaxosmithkline Chan; Henry A. Kelly; Nigel Paul King; Savvas Kleanthous; Andrew McMurtrie GlaxoSmithKline Mason; Stefan Senger; Paul W. Smith; Nigel S. Watson; Robert J. Young

Archive | 1999